The quinolinic acid model of Huntington's disease: Locomotor abnormalities
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 105 (1) , 45-53
- https://doi.org/10.1016/0014-4886(89)90170-2
Abstract
No abstract availableThis publication has 42 references indexed in Scilit:
- Model of Huntington's DiseaseScience, 1988
- Response : Model of Huntington's DiseaseScience, 1988
- Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neuronsBrain Research, 1987
- No evidence for preservation of somatostatin-containing neurons after intrastriatal injections of quinolinic acidNature, 1987
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986
- Short- and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidenced by GFA immunohistochemistry of astrocytesBrain Research, 1986
- Differential effect of kainic acid on somatostatin, GABAergic and cholinergic neurons in the rat striatumNeuroscience Letters, 1985
- Somatostatin is increased in the nucleus accumbens in Huntington's diseaseNeurology, 1984
- Somatostatin is increased in the basal ganglia in Huntington diseaseAnnals of Neurology, 1983
- The role of epileptic activity in hippocampal and ‘remote’ cerebral lesions induced by kainic acidBrain Research, 1980